In China, the incidence and mortality rate of lung cancer has exhibited an increasing trend over the past decades [ 2 ].
← all excerpts
Monotherapy of PD-1 Inhibitor Camrelizumab Reverses Advanced Lung Squamous Cell Carcinoma with Low PD-1 Expression: A Case Report.
1
—
—